Pharmaceutical Technology

MAY 28, 2023

Analysis of the key themes driving M&A activity reveals that orphan designated drugs accounted for 20 pharmaceutical deals announced in Q1 2023, worth a total value of $50.2bn. The $43bn acquisition of Seagen by Pfizer was the industry’s largest disclosed deal. GlobalData’s New Drug Approvals and Their Contract Manufacture report provides critical insight into the contract manufacturing organization (CMO) industry by analysing relative performance of major CMOs by number of drug

Pharmaceutical 85

Pharmaceutical Manufacturing Consulting 85

Cesare Ferrari

MAY 28, 2023

Measuring customer satisfaction is a cost-effective way to build brand loyalty, increase word-of-mouth marketing and differentiate your business from the competition. While large MedTech companies are systematically measuring how they are perceived by their customers and identifying the factors shaping customer satisfaction, small and medium businesses are still picking up.

Marketing 52

Marketing Sales Competition Medical 52

Pharmaceutical Technology

MAY 28, 2023

AstraZeneca has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its Ultomiris (ravulizumab) to prevent relapses in patients with neuromyelitis optica spectrum disorder (NMOSD), including neuromyelitis optica. The rare and debilitating autoimmune condition NMOSD affects the central nervous system (CNS), including optic nerves and the spine.

Safety 52

Safety Recruitment Patients 52

Pharmaceutical Technology

MAY 28, 2023

Analysis of the key themes driving M&A activity reveals that immuno-oncology accounted for 12 pharmaceutical deals announced in Q1 2023, worth a total value of $43.4bn. The $43bn acquisition of Seagen by Pfizer was the industry’s largest disclosed deal. A detailed classification of therapy and technologies, regulatory and market access details and pipeline analysis for immuno-oncology are included in GlobalData’s Immuno-Oncology – Thematic Research report.

Pharmaceutical 52

Pharmaceutical Marketing 52

Advertisement

Distribution

Pharmaceutical Technology

MAY 28, 2023

Analysis of the key themes driving M&A activity reveals that virtual care accounted for 6 pharmaceutical deals announced in Q1 2023, worth a total value of $426.2m. The $250m merger of Clearday and Viveon Health Acquisition and 98point6 was the industry’s largest disclosed deal. GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 report provides key insights into business strategies, trends driving the telehealth market and granular data on ma

Pharmaceutical 52

Pharmaceutical Marketing 52